On the HCPLive news page, resources on the topics of disease- and specialty-specific medical news and expert insight can be found. Content includes articles, interviews, videos, podcasts, and breaking news on health care research, treatment, and drug development.
Study: Insulin Shelf Life Could Be 4 Times Longer than Previously Reported
April 12th 2023A new pilot study assessing the shelf life of insulin when stored at room temperature during the summer in India suggests most insulins maintained 95% potency or greater at 4 months relative to refrigerated insulin.
Study Details Perceptions of Biosimilars Among Patients with Immune-Mediated Diseases
April 11th 2023An analysis of survey data from 500 patients with immune-mediated diseases, including rheumatoid arthritis, psoriasis, and IBD, suggests fewer than 1-in-4 patients were knowledgeable on the concept of biosimilars, but were open to learning more and considering use.
New Study Explores Racial Disparity in HBV Treatment Initiation
The cumulative probabilities of treatment initiation after meeting the criteria was not significantly different between the different racial groups and the incidence of major adverse liver outcomes was 0.1 per 100 person-years and did not differ by race.
Orman Trent Hall, DO: Fibromyalgia Rates Significantly Higher in Patients With Opioid Use Disorder
Results of a recent study found that fibromyalgia may be more common among individuals with opioid use disorder, and that treating fibromyalgia may be beneficial for treating opioid use disorder.
Phase 4 Trial Reports Positive Data on Teprotumumab for Thyroid Eye Disease
April 10th 2023Announced today by Horizon Therapeutics, the positive and statistically significant data supports the efficacy of teprotumumab across a spectrum of patients with TED regardless of disease activity or duration.
Hyporesponsiveness to CKD Therapy Increases RBCTs in Medicare Patients
April 10th 2023Hyporesponse to erythropoiesis-stimulating agents was associated with increased rates of red blood cell transfusions and poorer outcomes in patients with chronic kidney disease, highlighting the need for alternative anemia treatments.